Weill Cornell Medicine and NewYork-Presbyterian investigators have built a machine-learning tool that can predict SARS-CoV-2 infection based on age, gender, race and 27 routine laboratory test results.
With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a letter published Aug. 20 in Nature Biotechnology.
Ear, nose and throat (ENT) faculty discuss how Weill Cornell Medicine has safely and efficiently reopened outpatient otolaryngology following disruption to practice because of COVID-19.
Neurological complications ranging from headache, malaise and loss of smell to confusion and disabling strokes have been a disturbing consequence of COVID-19.
Two papers from Weill Cornell Medicine and NewYork-Presbyterian investigators make recommendations on addressing health disparities related to COVID-19 and broader social factors that impact patient health.
Two studies from Weill Cornell Medicine and NewYork-Presbyterian investigators suggest that maternal-to-child transmission of SARS-CoV-2 is rare; however, one study found that complications after birth occurred for some mothers infected with the virus.
Weill Cornell Medicine and NewYork-Presbyterian clinicians shared strategies that have been implemented at NewYork-Presbyterian/Weill Cornell Medical Center to meet the unprecedented need for critical care and recovery from COVID-19 in two recently published papers.
A common ear, nose, and throat (ENT) office procedure that involves examining a patient’s throat, known as a laryngoscopy, does not produce aerosol droplets any more than speaking or breathing, according to a study published by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Weill Cornell Medicine and NewYork-Presbyterian investigators examined patient data to determine how obesity and inflammatory bowel disease affect SARS-CoV-2 infection and the course of COVID-19.
Clinicians and investigators from Weill Cornell Medicine and NewYork-Presbyterian offer guidance on protecting older adults and building a stronger partnership between the medical and public health systems in two recently published papers on COVID-19.
With COVID-19 limiting resources and presenting logistical challenges for elective treatments, Weill Cornell Medicine and NewYork-Presbyterian clinicians offer guidance on treating cancer in three recently published papers.
When COVID-19 first appeared in NYC hospitals, Weill Cornell Medicine and NewYork-Presbyterian physicians and scientists documented early observations of clinical and pathological characteristics in two publications.
HIV epidemics are emerging and growing among female sex workers and their male clients in multiple countries in the Middle East and North Africa, and few of these epidemics have already reached their peak.
Responding to the growing prevalence of obesity in the United States, an alliance of professional medical societies has developed the first competencies for training and evaluating medical students, residents and fellows on preventing, assessing and treating the condition. The new competencies were published June 24 in the journal Obesity and highlighted as an Editor’s Choice article.
High-need, high-care patients taking part in focus group discussions arranged by Weill Cornell Medicine researchers have identified steps for reducing overuse of emergency departments and other hospital services to deliver effective care in less expensive ways.
Weill Cornell Medicine researchers have shown that giving mice with triple-negative breast cancer therapeutic microRNA (miRNA) in a protective gold nanoparticle results in significantly less spreading of cancer to the lung.
